Septerna (SEPN) Research & Development (2023 - 2026)
Septerna's (SEPN) quarterly Research & Development came in at $29.5 million in Q1 2026, up 53.26% year-on-year from $19.3 million in Q1 2025, and down 7.3% quarter-over-quarter from $31.9 million in Q4 2025.
Septerna (SEPN) Research & Development (2023 - 2026) Analysis & Trends
Septerna's Research & Development history runs 4 years deep, the most recent figure standing at $29.5 million for Q1 2026.
- On a quarterly basis, Research & Development rose 53.26% year-over-year to $29.5 million in Q1 2026; TTM through Mar 2026 was $107.8 million, a 50.93% increase from a year earlier, with the FY2025 full-year figure at $97.6 million, up 49.35% from the prior year.
- Research & Development declined to $29.5 million in Q1 2026 per SEPN's latest filing, from $31.9 million in the prior quarter.
- Across five years, Research & Development topped out at $31.9 million in Q4 2025 and bottomed at $9.3 million in Q3 2023.
- The 4-year median for Research & Development is $19.3 million (2025), against an average of $19.3 million.
- Across the five-year window, Research & Development jumped 92.13% in 2024 and jumped 36.07% in 2025, its largest moves.
- Year by year, Research & Development stood at $10.3 million in 2023, then soared by 87.07% to $19.3 million in 2024, then jumped by 64.94% to $31.9 million in 2025, then fell by 7.3% to $29.5 million in 2026.
- Per Business Quant, the three latest SEPN Research & Development figures stand at $29.5 million (Q1 2026), $31.9 million (Q4 2025), and $24.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 1.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 541.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -443.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 343.97 Mn |
| 10 | Septerna | 1.48 Bn | 1.48 Bn | - | 29.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.54 Mn |
| Dec 31, 2025 | 31.86 Mn |
| Sep 30, 2025 | 24.26 Mn |
| Jun 30, 2025 | 22.19 Mn |
| Mar 31, 2025 | 19.27 Mn |
| Dec 31, 2024 | 19.32 Mn |
| Sep 30, 2024 | 17.83 Mn |
| Jun 30, 2024 | 15.04 Mn |
| Mar 31, 2024 | 13.15 Mn |
| Dec 31, 2023 | 10.33 Mn |
| Sep 30, 2023 | 9.28 Mn |